- Home
- HBCP vs NGNE Comparison
HBCP vs NGNE Comparison
Compare HBCP & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBCP
- NGNE
- Stock Information
- Founded
- HBCP 1908
- NGNE 2003
- Country
- HBCP United States
- NGNE United States
- Employees
- HBCP N/A
- NGNE N/A
- Industry
- HBCP Banks
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- HBCP Finance
- NGNE Health Care
- Exchange
- HBCP Nasdaq
- NGNE Nasdaq
- Market Cap
- HBCP 398.8M
- NGNE 471.1M
- IPO Year
- HBCP 2008
- NGNE N/A
- Fundamental
- Price
- HBCP $49.38
- NGNE $34.52
- Analyst Decision
- HBCP Buy
- NGNE Strong Buy
- Analyst Count
- HBCP 2
- NGNE 6
- Target Price
- HBCP $46.50
- NGNE $63.80
- AVG Volume (30 Days)
- HBCP 31.0K
- NGNE 353.3K
- Earning Date
- HBCP 10-17-2024
- NGNE 11-15-2024
- Dividend Yield
- HBCP 2.11%
- NGNE N/A
- EPS Growth
- HBCP N/A
- NGNE N/A
- EPS
- HBCP 4.51
- NGNE 0.18
- Revenue
- HBCP $130,219,000.00
- NGNE $925,000.00
- Revenue This Year
- HBCP N/A
- NGNE N/A
- Revenue Next Year
- HBCP $4.36
- NGNE N/A
- P/E Ratio
- HBCP $10.95
- NGNE $189.06
- Revenue Growth
- HBCP N/A
- NGNE N/A
- 52 Week Low
- HBCP $33.30
- NGNE $12.49
- 52 Week High
- HBCP $52.39
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- HBCP 58.93
- NGNE 35.74
- Support Level
- HBCP $50.18
- NGNE $35.60
- Resistance Level
- HBCP $52.02
- NGNE $43.24
- Average True Range (ATR)
- HBCP 1.86
- NGNE 6.02
- MACD
- HBCP 0.06
- NGNE -2.86
- Stochastic Oscillator
- HBCP 57.72
- NGNE 0.00
About HBCP Home Bancorp Inc.
Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities. The principal sources of funds are customer deposits, repayments of loans, repayments of investments and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans. Its primary expenses are interest expense on deposits and borrowings and general operating expenses.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.